Literature DB >> 2480052

Acute acoustic trauma. A retrospective study of influencing factors and different therapies in 268 patients.

K Tschopp1, R Probst.   

Abstract

The files of 268 patients with acute acoustic trauma acquired during military service were analysed in a retrospective study. The following factors were examined: age, profession, degree of hearing loss, audiometric contour, and drug treatment. No influence of age or profession on recovery of hearing loss could be detected. The absolute hearing gain, defined as the difference between the hearing loss at onset and, on average, 7 days later, was dependent on the degree of initial hearing loss. The relative hearing gain, defined as absolute hearing gain divided by initial hearing loss, was independent of the degree of initial injury. The audiometric contour after the acoustic trauma had no prognostic relevance. Nine different types of drug treatment were compared in a subgroup of patients (n=199), in all of whom treatment was started within 2 days of the acoustic trauma. There were no significant differences in relative hearing gain between the nine types of treatment. Patients receiving early treatment had significantly better hearing one week after the acoustic trauma, as compared with the group of patients (n=69) not receiving treatment during the first 7 days. However, it was not possible to determine retrospectively whether this difference was due to treatment effects, or whether it was due to the exclusion of spontaneous remissions among those who were neither examined nor treated within the first 7 days.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2480052     DOI: 10.3109/00016488909125543

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  1 in total

1.  Potential efficacy of early treatment of acute acoustic trauma with steroids and piracetam after gunshot noise.

Authors:  George Psillas; Pavlos Pavlidis; Ioannis Karvelis; George Kekes; Victor Vital; John Constantinidis
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-05-08       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.